I would be interested in other posters' views about the following quote from the announcement... @Scarpa@anatol@Process1 or indeed other contributions are welcome.
"Full nameplate production of 3Mtpa is expected by theend of Q1 CY2025 with lithium recoveries expected to be optimised over the next 12-to-18-month period."
My take on it is that through this period the company will continually review the outcomes - of quality versus quantity versus recoveries - so that they can optimise the profitability of the scenarios. It was clearly stated at the last AGM that the intention/aim was to produce 6% concentrate. That is in spite of the possible capability of producing a higher grade at a still robust recovery rate. I may be "gilding the lily" to say this, but I imagine if all goes well, the potential recovery rate for high spec (for deleterious elements) 6% concentrate might be possible at higher recoveries than the forecast 78%-82%...say 85%? If that happens to deliver more bottom line benefit than producing say 6.3% concentrate, or perhaps higher spec output, then that is how they will set up the plant for "steady state" production.
What I do not think it means is that they have any doubt about achieving their targeted recovery at around 80% for SC6 from the getgo.
Regards
DF
- Forums
- ASX - By Stock
- LTR
- Ann: First production delivered on schedule at Kathleen Valley
Ann: First production delivered on schedule at Kathleen Valley, page-89
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
87.5¢ |
Change
0.035(4.17%) |
Mkt cap ! $2.121B |
Open | High | Low | Value | Volume |
85.0¢ | 89.5¢ | 84.5¢ | $14.42M | 16.61M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 112120 | 87.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
87.5¢ | 79469 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 112120 | 0.870 |
4 | 93230 | 0.865 |
5 | 77327 | 0.860 |
4 | 161823 | 0.855 |
10 | 425000 | 0.850 |
Price($) | Vol. | No. |
---|---|---|
0.875 | 79469 | 3 |
0.880 | 20475 | 3 |
0.885 | 7190 | 2 |
0.890 | 340248 | 14 |
0.895 | 160337 | 15 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online